Opioid addiction: what it is, why it happens, and what recovery looks like

Opioid dependency can begins with prescribed medication. Someone is in pain. A doctor prescribes an opioid. The medicine works. Over time, the dose may need to increase to maintain the same level of relief. By the time a problem becomes visible, the person may have been following their prescription carefully and may have had no intention, or awareness, of developing a dependency.

This is simply a result of the properties of opioids, specifically tolerance and physical dependence – receiving a prescription can carry inherent risk regardless of the individual.

A 2025 national cohort study published in Communications Medicine, which followed over 750,000 opioid-naive individuals in Sweden, found that the most significant risk factor for developing long-term opioid use was not a characteristic of the individual. It was receiving an opioid prescription itself. Of those who received an initial prescription, 8.1% went on to use opioids long-term. 

• Needing a higher dose than prescribed to achieve the same level of pain relief
• Experiencing physical symptoms such as sweating, nausea, muscle aches, or anxiety when a dose is missed or delayed
• Finding that the time between doses feels increasingly difficult to manage
• Continuing to use opioids despite concerns about the effect on your health, relationships, or daily life

• Low mood, irritability, or anxiety between doses
• Spending increasing time thinking about medication or making sure you have enough
• Withdrawing from activities or relationships that once mattered
• A growing sense of secrecy around your medication use

Yet these all exist on a spectrum. Dependency does not have a single entry point, and the presence of even a few of these patterns is often a serious point of concern.

For people using opioids under a prescription, the signs can look different from those associated with illicit drug use. Dose escalation, taking more than prescribed or taking doses closer together than directed, is often the earliest visible sign. 

You might also notice that opioids are being used for reasons beyond the original pain, for example to manage stress, anxiety, or low mood, or to feel able to cope with the day. This is the brain’s reward system responding to a substance that reliably reduces discomfort, also serving as a sign that dependency has moved beyond physical pain management.

• A personal or family history of substance dependency
• Chronic pain conditions, which increase both exposure to opioids and the duration of use
• Prior trauma, post-traumatic stress disorder (PTSD), anxiety, or depression. This is not because these experiences directly cause opioid dependency, but because opioids are effective at temporarily relieving emotional as well as physical pain. Research published by the National Institutes of Health in the United States identifies these conditions as among the most established co-occurring risk factors
• Receiving an initial opioid prescription in a primary care setting rather than for an acute injury. According to the 2025 Swedish cohort study (Kruger et al., 2025), this is associated with three times the odds of long-term use
• Social factors including isolation, unemployment, and limited access to non-opioid pain management or mental health support

It is also worth noting that women are, on average, more likely than men to be prescribed opioids, to receive higher doses, and to use them for longer periods. This means the risk picture is not uniform across gender, even if the experience of opioid dependency cuts across all demographics. 

A multinational European cohort study found that risk factors for prolonged use, including chronic pain, mental health conditions, and older age, are common across European populations.

Effective treatment for opioid dependency typically combines medically assisted detox with psychological therapy. Approaches such as Cognitive Behavioural Therapy (CBT), motivational interviewing, and group therapy address the patterns of thinking and behaviour that sustain dependency. Detox addresses the physical component. Aftercare and ongoing support are not optional extras. They are part of what makes recovery last.

According to the EUDA, effective long-term treatment for opioid dependency often involves multiple treatment episodes and combinations of approaches. Treatment using medicines such as methadone or buprenorphine is the most established pharmacological approach, and evidence shows it reduces both illicit opioid use and mortality. Its effects are further enhanced when combined with psychosocial support.

What the evidence also shows is that recovery is a process, and for most people it involves more than one episode of support. Periods of greater stability and periods of difficulty are both part of the process. Relapse is common, and it is a recognised feature of what is, clinically, a long-term condition. It is not a sign of failure. Understanding that relapse does not equate to failure can make what feels like an “unlit path” easier to navigate.

If you want to understand what treatment actually involves, our opioid addiction treatment page covers this in detail. If you are not ready for that yet, this page will be here when you are.

These terms are often used interchangeably, but they’re clinically distinct. Physical dependence, meaning the body has adapted to the presence of opioids and will produce withdrawal symptoms without them, can develop without the loss-of-control element that characterises addiction. People can find stopping extremely difficult even without meeting the full clinical criteria for opioid use disorder. For that reason, we should remember the importance of the distinction, because it explains why stopping is difficult even for people who do not consider themselves dependent in the broader sense.

Yes. Physical dependence can develop through prescription use, particularly over longer periods or at higher doses. It does not mean that everyone who takes prescribed opioids will develop a problem. But research published in Communications Medicine has described the receipt of an opioid prescription as itself the primary risk factor for long-term use, not any particular characteristic of the person receiving it (Kruger et al., 2025).

Opiates are naturally occurring compounds derived from the opium poppy. Morphine, codeine, and heroin fall into this category. Opioids is the broader term that covers the whole class, including synthetic and semi-synthetic compounds designed to act on the same receptors in the brain. Fentanyl and methadone are examples of synthetic opioids. In clinical and everyday use, ‘opioids’ is now the standard umbrella term, and that is the convention used throughout this page.

Synthetic opioids, particularly illicitly manufactured fentanyl and its analogues, are significantly more potent than most prescription opioids. Research published in JA Open (Lambert, 2023) notes that fentanyl is approximately 80 times more potent than morphine, which means the margin between a dose that produces an effect and one that causes overdose is considerably smaller. The contamination of the illicit drug supply with synthetic opioids has increased overdose risk substantially across Europe. EUDA data from 2023 recorded a significant increase in seizures of nitazenes and other novel synthetic opioids across EU member states (EUDA, 2025). That said, risk is not simply a function of substance type. Tolerance, route of use, and whether other substances are involved all significantly affect the picture.

Opioid dependency affects the people around the person using it, not just the person themselves. If you are worried about someone in your life, support exists specifically for you, not only for them. Family therapy and support for making sense of what you are witnessing are both available through Castle Health. Reaching out does not require the person you are worried about to be ready for treatment. You can take that step for yourself, at any point.